HER-2 Positive Breast Cancer Market in the US 2015-2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
HER-2 Positive Breast Cancer Market in the US
2015-2019
2
Description
Report Overview
About HER-2 Positive Breast Cancer Breast cancer
is characterized by uncontrolled growth of
cancerous cells in the breast. It occurs in both
males and females, however, the incidence of
breast cancer in males is rare. Histologically,
breast cancer can be classified into ductal
carcinoma, lobular carcinoma, nipple cancer, and
other undifferentiated carcinoma. Breast cancer
is the second most common form of cancer in
women. HER-2 is a protein that affects the growth
of malignant cells and is usually found on the
surface of normal breast cells. Sometimes, a
large number of HER-2 receptors are found on the
surface of breast cancer cells. These HER-2
receptors are responsible for stimulating the
growth and division of malignant cancerous cells.
This condition is therefore known as HER-2
positive breast cancer. HER-2 positive breast
cancers have a tendency to spread and metastasize
more rapidly than HER-2 negative breast cancers.
Analysts forecast the HER-2 Positive Breast
Cancer market in US to grow at a CAGR of 12.65
percent over the period 2014-2019. Read more
details _at_ http//www.bigmarketresearch.com/her-2-p
ositive-breast-cancer-in-the-us-2015-2019-market
_at_Bigmarketresearch
3
Description
Report Overview
This report covers the present scenario and the
growth prospects of the HER-2 Positive Breast
Cancer market in the US for the period 2015-2019.
To calculate the market size, the report
considers revenue generated through the sales of
targeted therapeutics and chemotherapeutics used
in the management of HER-2 positive breast cancer
patients. The report also presents the vendor
landscape and a corresponding detailed analysis
of the top vendors in the HER-2 Positive Breast
Cancer market in the US. In addition, it
discusses the major drivers that influence the
growth of the market. It also outlines the
challenges faced by the vendors and the market at
large, as well as the key trends that are
emerging in the market. HER-2 Positive Breast
Cancer Market in US 2015-2019, has been prepared
based on an in-depth market analysis with inputs
from industry experts. The report covers the
market landscape of the HER-2 Positive Breast
Cancer market in the US and its growth prospects
over the coming years. The report also includes a
discussion of the key vendors operating in this
market.
_at_Bigmarketresearch
4
Description
Report Overview
Key Vendors Celgene F. Hoffmann-La Roche
GlaxoSmithKline Novartis Sanofi Other
Prominent Vendors Bristol-Myers Squibb DARA
BioSciences Eisai Hospira Pfizer
ProStrakan Sun Pharmaceutical Industries
Teva Pharmaceutical
_at_Bigmarketresearch
5
Description
Report Overview
Market Driver Increase in Population of Breast
Cancer Patients For a full, detailed list, view
our report Market Challenge Poor Diagnosis
and Screening For a full, detailed list, view
our report Market Trend Increase in
Awareness For a full, detailed list, view our
report Enquire About Report _at_ http//www.bigmarke
tresearch.com/report-enquiry/183633
_at_Bigmarketresearch
6
Table Of Contents
Table Of Content
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06. Disease
Overview 07. Market Landscape 08. Market
Segmentation by Type of Therapy 09.9 Market
Segmentation by Molecule Type 10 Market
Segmentation by Route of Administration 11 Buying
Criteria 12 Market Growth Drivers 13 Drivers and
their Impact 14 Market Challenges 15 Impact of
Drivers and Challenges 16 Market Trends 17 Trends
and their Impact 18 Vendor Landscape 19 Key
Vendor Analysis 20 Other Reports in this Series
_at_Bigmarketresearch
7
Get Full Information At http//www.bigmarketrese
arch.com/her-2-positive-breast-cancer-in-the-us-20
15-2019-market